This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USA

REGISTER A GROUP OF 3+ AND SAVE
Contact Jessica Purnell at jessica.purnell@informa.com to inquire about group rates.

LOOKING TO REGISTER FOR DIGITAL EXPERIENCE PASS?
Book the Digital experience pass HERE

QUESTIONS?
Contact Event Marketing Manager, Carter Anderson at Carter.Anderson@informa.com

Base Digital Experience Pass option does NOT include access to any of the pre-conference workshops on May 7. The May 7 workshops are not being recorded or streamed digitally.



Pre-Conference Workshops - May 7, 2023

(Choose 1 Morning and 1 Afternoon Workshop)

4 Morning Half-Day Workshops • 8:00am-12:00pm 

1) Introduction to Oligonucleotides

Workshop Leader: Mike Webb, Ph.D., Founder and CEO, Mike Webb Pharma


2) Impurities in Oligonucleotides: Sources, Analysis and Control 

Workshop Leaders: G. Susan Srivatsa, Ph.D., President, ElixinPharma & Fran Wincott, Ph.D., President, Wincott & Associates, LLC


3) Introduction to Genome Editing 

Workshop Leaders: Rubina Parmar, Ph.D., Vice President, Chemistry and Delivery Sciences, Intellia Therapeutics & Cecilia Fernandez, Ph.D., VP of Strategic Planning and Operations, Chroma Medicine


4) Peptide Workshop

Workshop Leader TBA


4 Afternoon Half-Day Workshops • 1:00pm-5:00pm


1) The Next Wave of LNP Applications for mRNA and Nucleic Acids 

Workshop Leader: Ed Yaworski, Chief Technology Officer, Genevant


2) Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides 

Workshop Leader: Mike Webb, Ph.D., Founder and CEO, Mike Webb Pharma


3) Going Green: Sustainability in Oligonucleotide Manufacturing for Late Stage Programs

Workshop Leaders: Claus Rentel, Ph.D., Executive Director, Analytical Development/QC, Ionis Pharmaceuticals & Biospring


4) New Peptide Drug Requirements for Nitrosamine, Mutagenic and Genotoxic Impurities

Workshop Leader: Trishul Shah, Director, Business Development, North America, PolyPeptide Laboratories


Package discounts available
$100 reduction if buying both add-ons

Delegate Type

help_outlineSave up to $1,200.00 when you book by 16 December

Create Your Package

Select an item from the list below

TIDES USA In-Person Conference Pass Options:

Please select one option
Please select one option
Save $1,000.00 when you book by 16 December
Save $1,200.00 when you book by 16 December

Get more from your event

Add-Ons

Your Price

Quantity
Subtotal
$0.00
Total
$0.00